• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Epocrates ponies up $14 million for iPad app developer Modality

Epocrates ponies up $14 million for iPad app developer Modality

November 18, 2010 By MedCity News

MedCity News logo

Epocrates Inc. acquired Modality Inc. of Durham, N.C., for $13.8 million in cash.

Modality develops digital learning, assessment, training and reference applications for Apple iPad, iPhone and iPhone Touch mobile devices. Its acquisition will expand San Mateo, Calif.-based Epocrates’ product portfolio and Apple app-development workforce.

“We have the trust of more than one million healthcare professionals, and with Modality, a richer, advanced Apple development expertise,” Epocrates CEO Rose Crane said in prepared remarks. “Together, we will cultivate even more cutting-edge and indispensable apps for clinicians that directly impact patient care.”

Used by more than 175,000 U.S. physicians, Epocrates is the top drug reference application on Apple mobile technologies, the company said. With Modality’s Internetwork Operating System development expertise, Epocrates will try to churn out more new education and resource apps for clinicians.

Yesterday, Epocrates updated its registration statement for an initial public offering that could raise as much as $75 million. Epocrates plans to use the money raised through the offering to pay $28.6 million-worth of preferred stock dividends, as well as for working capital, research and development, sales and marketing and capital expenditures.

It’s the company’s second shot at an IPO. Epocrates filed for a $75 million initial public offering in 2008, then pulled the filing after the U.S. economic crisis began.

For the nine months ended Sept. 30, Epocrates had a net loss attributable to common shareholders of $1.5 million, or a loss of 16 cents a share, on revenues of $73.7 million. That compared to net income of $702,000 on revenues of $66.2 million, or 6 cents a share, in the same 2009 period. The company had 292 employees as of Sept. 30.

Filed Under: Business/Financial News, Digital Health, Mergers & Acquisitions, News Well, Software / IT Tagged With: Epocrates, Modality Inc.

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy